SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences board declares interim dividend

20 Oct 2016 Evaluate

Hester Biosciences has informed that the Board of Directors of the Company at its meeting held on October 20, 2016, has declared an interim dividend of 30 percent, i.e. Rs 3 per equity share on the face value of Rs 10 per share, for the financial year 2016-17. The Board of Directors has also considered the revision in Remuneration and Re-appointment of Rajiv Gandhi as a CEO & Managing Director subject to approval of Shareholders and Central Government, if any.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1649.65 11.45 (0.70%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×